GenoMEL – the Melanoma Genetics Consortium


	GenoMEL is an international research consortium coordinated by the University of Leeds.


















































	Terms and Conditions Privacy Statement



	Translations by: The LUMC team, particularly Frans van Nieuwpoort

GenoMEL is a FP6 project and
as such is funded by the European Commission

Project title: Genetic and environmental risk factors for melanoma: translation into behavioural change.

Project number: 018702
Project type: Network of Excellence
Project duration:5 and a half years from Dec 05

We are a world leader in familial melanoma research.
Our website contains a wealth of information about our research consortium and includes interactive materials for melanoma patients, their families and the general public.



GenoMEL has produced an online tutorial entitled, ‘The Early Diagnosis of Melanoma’. Promoting better outcomes for melanoma patients through earlier diagnosis and treatment is the purpose of this package. Primary healthcare workers and specialists in training are the intended audience, although experienced clinicians and patients may also find it useful. The tutorial contains text, photographs, videos, clinical cases and a self assessment section. To view the tutorial please click here. We are also producing a small number of CDs containing the tutorial. If you would like a CD version, or have any comments, please email us at info@genomel.org




Predicting Benefit from Interferon Therapy in Melanoma This section is for people who participated in the following European interferon trials: AIM HIGH EORTC 18952 EORTC 18991 Our research team in Leeds has obtained ethical permission to use the data and samples gathered as part of these studies for a new study. For more details please see the study leaflet. There is also further information for clinicians about the study in the study protocol.

Study Leaflet Study Protocol

For further information please contact: Dr. Rosalyn Jewell r.a.jewell@leeds.ac.uk Section created: 19/12/08










GenoMEL is a FP6 project and as such is funded by the European Commission	GenoMEL also receives substantial support from the National Cancer Institute (NCI) of the US National Institutes of Health (NIH) (CA83115).

100,000 visitors
The GenoMEL website has now received over 100,000 visitors! If you have any thoughts on how we can improve this website please get in touch.

New GenoMEL tutorial promoting dermoscopy
GenoMEL has created a new tutorial for clinicians. This tutorial is a basic introduction to dermoscopy and contains 100’s of images to help clinicians develop their diagnostic skill. Dermoscopy is a technique that improves the early recognition of melanoma. To view the tutorial please click here.

The ‘Predicting Benefit from Interferon Therapy in Melanoma’ study
GenoMEL’s Leeds team is conducting a study using information and samples from the following European interferon studies: AIM HIGH, EORTC 18952 and EORTC 18991. If you would like further information please see the main panel to the left.

Meetings in 2010

January
16-17 January, 20th Annual Cutaneous Malignancy Update, San Diego, USA

29 January, Melanoma Study Group, London, UK

June
4-8 June, American Society of Clinical Oncologyannual meeting, Chicago, USA

17-19 June, 6th Congress of the European Association of Dermatologic Oncology (EADO), Athens, Greece

22-24 June, annual GenoMEL meeting, Leeds, UK

25 June, Melanoma Study Group, Leeds, UK

September
18-19 September, Perspectives in Melanoma XIV Amsterdam, The Netherlands

October
6-10 October, 19th EADV Congress, Gothenburg, Sweden

November
4-7 November, 7th Annual International Melanoma Research Congress & 4th Meeting of Interdisciplinary Melanoma/Skin Cancer Centers , Sydney, Australia

Meetings in 2011

Spring/early Summer
Annual GenoMEL meeting - Tel Aviv, Israel

If you have any comments on this news section, or on the website in general, please contact us at info@genomel.org

website design: NKD | email: info@NKD.org.uk | site: www.NKD.org.uk

Content on this page requires a newer version of Adobe Flash Player.